Our results confirm that CD200 is a valuable marker in confirming the diagnosis of CLL and HCL, adding CD200 to the routine testing panel will aid in differentiating between CLL and MCL in cases with overlapping immunophenotyping results. The gene discussed is CD200; the disease is hairy cell leukemia.